Literature DB >> 10949655

Endothelial receptor tyrosine kinases involved in blood vessel development and tumor angiogenesis.

G Breier1.   

Abstract

Entities:  

Mesh:

Substances:

Year:  2000        PMID: 10949655     DOI: 10.1007/978-1-4615-4221-6_5

Source DB:  PubMed          Journal:  Adv Exp Med Biol        ISSN: 0065-2598            Impact factor:   2.622


× No keyword cloud information.
  7 in total

Review 1.  Mathematical modeling of tumor-induced angiogenesis.

Authors:  Nikos V Mantzaris; Steve Webb; Hans G Othmer
Journal:  J Math Biol       Date:  2004-02-06       Impact factor: 2.259

2.  Substitution of C-terminus of VEGFR-2 with VEGFR-1 promotes VEGFR-1 activation and endothelial cell proliferation.

Authors:  Rosana D Meyer; Amrik Singh; Fredric Majnoun; Catharina Latz; Kameran Lashkari; Nader Rahimi
Journal:  Oncogene       Date:  2004-07-15       Impact factor: 9.867

3.  The antihypertension drug doxazosin inhibits tumor growth and angiogenesis by decreasing VEGFR-2/Akt/mTOR signaling and VEGF and HIF-1α expression.

Authors:  Mi Sun Park; Boh-Ram Kim; Seung Myung Dong; Seung-Hoon Lee; Dae-Yong Kim; Seung Bae Rho
Journal:  Oncotarget       Date:  2014-07-15

4.  Thioridazine inhibits angiogenesis and tumor growth by targeting the VEGFR-2/PI3K/mTOR pathway in ovarian cancer xenografts.

Authors:  Mi Sun Park; Seung Myung Dong; Boh-Ram Kim; Seung Hee Seo; Sokbom Kang; Eun-Ju Lee; Seung-Hoon Lee; Seung Bae Rho
Journal:  Oncotarget       Date:  2014-07-15

5.  sMEK1 inhibits endothelial cell proliferation by attenuating VEGFR-2-dependent-Akt/eNOS/HIF-1α signaling pathways.

Authors:  Boh-Ram Kim; Seung Hee Seo; Mi Sun Park; Seung-Hoon Lee; Youngjoo Kwon; Seung Bae Rho
Journal:  Oncotarget       Date:  2015-10-13

6.  Tanshinone IIA combined with adriamycin inhibited malignant biological behaviors of NSCLC A549 cell line in a synergistic way.

Authors:  Jun Xie; Jia-Hui Liu; Heng Liu; Xiao-Zhong Liao; Yuling Chen; Mei-Gui Lin; Yue-Yu Gu; Tao-Li Liu; Dong-Mei Wang; Hui Ge; Sui-Lin Mo
Journal:  BMC Cancer       Date:  2016-11-18       Impact factor: 4.430

7.  The anti-psychotic drug pimozide is a novel chemotherapeutic for breast cancer.

Authors:  El-Habib Dakir; Adam Pickard; Kirtiman Srivastava; Cian M McCrudden; Stephane R Gross; Stephen Lloyd; Shu-Dong Zhang; Andriana Margariti; Richard Morgan; Philip S Rudland; Mohamed El-Tanani
Journal:  Oncotarget       Date:  2018-10-09
  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.